Chandler Julia M, Kim Minji, Sevilimedu Varadan, Le Tiana V, Nelson Jonas A, Braunstein Lior Z, Morrow Monica, Lee Minna K, Tadros Audree B
Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18095-x.
Although several trials have demonstrated the oncologic safety of partial-breast irradiation (PBI) compared with whole-breast irradiation (WBI), data on patient-reported outcomes are mixed. Here we compare breast satisfaction and chest well-being using the BREAST-Q questionnaire among patients undergoing PBI versus WBI.
We identified patients undergoing lumpectomy and radiation, and analyzed their BREAST-Q scores preoperatively and postoperatively at 6 months, 1 year, 2 years, and 3 years. We stratified patients by type of radiation, and compared breast satisfaction and chest well-being scores over time, and with univariate and multivariate analyses (MVA).
From 2017 to 2022, 6374 patients underwent lumpectomy and radiation, and responded to the BREAST-Q at ≥ 1 time point. For both breast satisfaction and chest well-being, patients undergoing PBI had higher preoperative scores. For breast satisfaction, scores increased for both groups postoperatively and remained above baseline through 3 years of follow-up; for chest well-being, scores decreased postoperatively and gradually increased. On MVA, radiation type was not significantly associated with either breast satisfaction or chest well-being at any postoperative time point. At the 2-year postoperative time point, receipt of adjuvant chemotherapy was associated with worse breast satisfaction, and BMI < 20 was associated with improved chest well-being.
Patients undergoing PBI and WBI had similar breast satisfaction and chest well-being at all postoperative time points. Other patient- and treatment-related variables such as body mass index (BMI), axillary surgery, and need for chemotherapy were significantly associated with long-term breast satisfaction and chest well-being. These findings support the use of PBI as an alternative to WBI in terms of patient-reported outcomes in eligible patients.
尽管多项试验已证明与全乳照射(WBI)相比,部分乳腺照射(PBI)在肿瘤学方面的安全性,但关于患者报告结局的数据却参差不齐。在此,我们使用BREAST-Q问卷比较接受PBI与WBI的患者的乳房满意度和胸部健康状况。
我们确定了接受保乳手术和放疗的患者,并分析了他们在术前以及术后6个月、1年、2年和3年的BREAST-Q评分。我们根据放疗类型对患者进行分层,并比较不同时间点的乳房满意度和胸部健康状况评分,同时进行单因素和多因素分析(MVA)。
2017年至2022年期间,6374例患者接受了保乳手术和放疗,并在≥1个时间点对BREAST-Q进行了回应。对于乳房满意度和胸部健康状况,接受PBI的患者术前评分更高。对于乳房满意度,两组患者术后评分均升高,并在3年随访期内一直高于基线水平;对于胸部健康状况,术后评分下降,随后逐渐升高。在多因素分析中,放疗类型在任何术后时间点均与乳房满意度或胸部健康状况无显著相关性。在术后2年的时间点,接受辅助化疗与较差的乳房满意度相关,而体重指数(BMI)<20与改善的胸部健康状况相关。
在所有术后时间点,接受PBI和WBI的患者的乳房满意度和胸部健康状况相似。其他与患者和治疗相关的变量,如体重指数(BMI)、腋窝手术和化疗需求,与长期乳房满意度和胸部健康状况显著相关。这些发现支持在符合条件的患者中,就患者报告结局而言,使用PBI作为WBI的替代方案。